Fluconazole impacts the extracellular matrix of fluconazole-susceptible and-resistant Candida albicans and Candida glabrata biofilms

被引:29
作者
Dias Panariello, Beatriz Helena [1 ]
Klein, Marlise, I [2 ]
De Oliveira Mima, Ewerton Garcia [2 ]
Pavarina, Ana Claudia [2 ]
机构
[1] Indiana Univ Purdue Univ, Sch Dent, Dept Cariol Operat Dent & Dent Publ Hlth, Indianapolis, IN 46202 USA
[2] Sao Paulo State Univ, Sch Dent, Dept Dent Mat & Prosthodont, Unesp, Araraquara, SP, Brazil
来源
JOURNAL OF ORAL MICROBIOLOGY | 2018年 / 10卷 / 01期
基金
巴西圣保罗研究基金会;
关键词
Biofilm; Candida albicans; Candida glabrata; extracellular matrix; fluconazole; fluconazole-resistant; IN-VITRO SUSCEPTIBILITY; DRUG-RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; TRANSCRIPTIONAL RESPONSE; STAPHYLOCOCCUS-AUREUS; AZOLE RESISTANCE; SPP; ITRACONAZOLE; QUANTITATION; INFECTIONS;
D O I
10.1080/20002297.2018.1476644
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Fluconazole (FLZ) is a drug commonly used for the treatment of Candida infections. However, -glucans in the extracellular matrices (ECMs) hinder FLZ penetration into Candida biofilms, while extracellular DNA (eDNA) contributes to the biofilm architecture and resistance. Methods: This study characterized biofilms of FLZ-sensitive (S) and -resistant (R) Candida albicans and Candida glabrata in the presence or absence of FLZ focusing on the ECM traits. Biofilms of C albicans American Type Culture Collection (ATCC) 90028 (CaS), C. albicans ATCC 96901 (CaR), C. glabrata ATCC 2001 (CgS), and C. glabrata ATCC 200918 (CgR) were grown in RPM! medium with or without FLZ at 5x the minimum inhibitory concentration (37 degrees C/48 h). Biofilms were assessed by colony-forming unit (CFU)/mL, biomass, and ECM components (alkali-soluble polysaccharides [ASP], water-soluble polysaccharides [WSP], eDNA, and proteins). Scanning electron microscopy (SEM) was also performed. Data were analyzed by parametric and nonparametric tests (a = 0.05). Results: In biofilms, FLZ reduced the CFU/mL of all strains (p < 0.001), except for CaS (p = 0.937). However, the ASP quantity in CaS was significantly reduced by FLZ (p = 0.034), while the drug had no effect on the ASP levels in other strains (p > 0.05). Total biomasses and WSP were significantly reduced by FLZ in the ECM of all yeasts (p < 0.001), but levels of eDNA and proteins were unaffected (p > 0.05). FLZ affected the cell morphology and biofilm structure by hindering hyphae formation in CaS and CaR biofilms, by decreasing the number of cells in CgS and CgR biofilms, and by yielding sparsely spaced cell agglomerates on the substrate. Conclusion: FLZ impacts biofilms of C. albicans and C. glabrata as evident by reduced biomass. This reduced biomass coincided with lowered cell numbers and quantity of WSPs. Hyphal production by C. albicans was also reduced.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole
    Bruzual, Igor
    Riggle, Perry
    Hadley, Susan
    Kumamoto, Carol A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (03) : 441 - 450
  • [42] The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms
    Jia, Wei
    Zhang, Haiyun
    Li, Caiyun
    Li, Gang
    Liu, Xiaoming
    Wei, Jun
    BMC MICROBIOLOGY, 2016, 16
  • [43] A mechanism study on the synergistic effects of rifapentine and fluconazole fluconazole-resistant Candida albicans in vitro
    Wang, Yulian
    He, Yufei
    Cai, Tongkai
    Lei, Zhongwei
    Lei, Wenzhi
    Cao, Yongbing
    Wu, Jianhua
    HELIYON, 2024, 10 (06)
  • [44] In vitro activity of verapamil alone and in combination with fluconazole or tunicamycin against Candida albicans biofilms
    Yu, Qilin
    Ding, Xiaohui
    Xu, Ning
    Cheng, Xinxin
    Qian, Kefan
    Zhang, Biao
    Xing, Laijun
    Li, Mingchun
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (02) : 179 - 182
  • [45] Candida albicans enhances iron uptake to maintain fluconazole resistance
    Sharma, Rishabh
    Nahar, Anubhav
    Puri, Sumant
    INFECTION AND IMMUNITY, 2025, 93 (03)
  • [46] Antimicrobial and anti-biofilm properties of oleuropein against Escherichia coli and fluconazole-resistant isolates of Candida albicans and Candida glabrata
    Esfandiary, Mohammad Ali
    Khosravi, Ali Reza
    Asadi, Sepideh
    Nikaein, Donya
    Hassan, Jalal
    Sharifzadeh, Aghil
    BMC MICROBIOLOGY, 2024, 24 (01)
  • [47] Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms
    Nagy, Fruzsina
    Toth, Zoltan
    Bozo, Aliz
    Czegledi, Andras
    Rebenku, Istvan
    Majoros, Laszlo
    Kovacs, Renato
    MEDICAL MYCOLOGY, 2019, 57 (05) : 573 - 581
  • [48] Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms
    Ramage, G
    Bachmann, S
    Patterson, TF
    Wickes, BL
    López-Ribot, JL
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (06) : 973 - 980
  • [49] The genetic basis of fluconazole resistance development in Candida albicans
    Morschhäuser, J
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (2-3): : 240 - 248
  • [50] In Vitro Study of Sequential Fluconazole and Caspofungin Treatment against Candida albicans Biofilms
    Sarkar, Semanti
    Uppuluri, Priya
    Pierce, Christopher G.
    Lopez-Ribot, Jose L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 1183 - 1186